Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.

How Much Will The Upstream Bioprocessing Market Be Worth By 2029?

The market size of upstream bioprocessing has experienced a swift expansion in the past few years. The projection is that it will surge from $12.03 billion in 2024 to $13.62 billion in 2025, recording a compound annual growth rate (CAGR) of 13.3%. Factors fueling growth during the historical period include the escalating need for process optimization, contamination-free, secure, and efficient production of biomolecules, commercial achievements, and the growing demand for biotherapeutics. There’s also been an increase in the use of process analytical technology, a rise in the prevalence of chronic illnesses, and heightened research into the production of biosimilars.

The market size for upstream bioprocessing is anticipated to experience swift expansion in the coming years, reaching a value of $21.78 billion in 2029 with a compound annual growth rate (CAGR) of 12.4%. The expected growth during the forecast period is due to factors such as the commercial application of single-use bioreactors, the trend of outsourcing biopharmaceutical production, the fast-paced growth of the pharmaceutical and biotech industries, increasing preference for single-use upstream bioprocessing, and a rise in alliances, mergers, acquisitions, and collaborative efforts. Key trends during the forecast period encompass rising research and development investments in the biopharmaceutical industry, advancements in technology, progress in upstream bioprocessing techniques, and the creation of new and advanced filtration technologies.

Get A Free Sample Of The Report:

https://www.thebusinessresearchcompany.com/sample.aspx?id=15950&type=smp

What Market Forces Are Contributing To The Growth Of The Upstream Bioprocessing Market?

The anticipated growth of the upstream bioprocessing market is being propelled by the outsourcing of biopharmaceutical manufacturing. This includes handing off various stages of production to external parties, which can be contract manufacturing organizations (CMOs) or contract development and manufacturing organizations (CDMOs). The reasons for this outsourcing range from cost efficiencies and concentration on core abilities to scalability in manufacturing, access to specialized knowledge, and lessening risks. The outsourcing process within the upstream bioprocessing market facilitates product advancement through the use of outside expertise, operation simplification, and cost reductions. As an example, BDO USA, an American team within BDO International, has projected that by 2025, contract development and manufacturing organizations, together with hybrid manufacturing companies, will hold 44% of the estimated 7,500kL global mammalian capacity. This highlights the pivotal role that outsourcing biopharmaceutical manufacturing plays in driving the upstream bioprocessing market’s expansion.

Which Segments Define The Structure Of The Upstream Bioprocessing Market?

The upstream bioprocessingmarket covered in this report is segmented –

1) By Product type: Bioreactors; Fermenters; Cell Culture Media; Filters; Bags And Containers

2) By Workflow: Media Preparation; Cell Culture; Cell Separation

3) By Usage type: Single-Use; Multi-Use

4) By Mode: In House; Outsourced

5) By End User: Contract Development and Manufacturing Organization (CDMOs) Or Contract Research Organization (CROs); Research And Academic Institutes; Biopharmaceutical Companies

Subsegments:

1) By Bioreactors: Single-Use Bioreactors; Multi-Use Bioreactors

2) By Fermenters: Laboratory Fermenters; Pilot Scale Fermenters; Industrial Fermenters

3) By Cell Culture Media: Powdered Media; Liquid Media

4) By Filters: Sterile Filters; Air Filters; Capsule Filters

5) By Bags And Containers: Single-Use Bags; Bioprocess Containers; Storage Bags

Which Long-Term Trends Will Play A Crucial Role In The Upstream Bioprocessing Market?

Major firms in the upstream bioprocessing sector are concentrating their efforts on creating enhanced bioreactors that can cater to the demands of cell culture procedures in terms of efficiency, adaptability, and scalability. Bioreactors play an integral role in upstream bioprocessing by facilitating the regulated and proficient production of biopharmaceuticals via cell culture and the generation of biomolecules. For example, in April 2023, Cytiva, a firm based in the US that offers life science products and solutions, brought to the market their X-platform bioreactors which aim to simplify single-use upstream bioprocessing tasks. These bioreactors are composed of a tank, a cabinet assembly, and a human-machine interface (HMI). The use of a modular layout allows for easy configurations, eliminating the need for bespoke hardware or single-use bags. The design also includes user-friendly aspects such as a vessel with a complete opening door, baffles, and advanced cable management. Furthermore, the Bioreactor Scaler online tool aids in determining the best parameters for effective scale-up.

Which Firms Are Making The Biggest Impact In The Upstream Bioprocessing Market?

Major companies operating in the upstream bioprocessing market are Thermo Fisher Scientific Inc., Danaher Corp, Merck KGaA, GE HealthCare Technologies, Parker Hannifin Corp, Corning Inc., AGC Biologics, Avantor, AGC Inc., Boehringer Ingelheim International GmbH, Catalent Inc., Sartorius AG, Entegris Inc., Getinge AB, Bio-Rad Laboratories Inc., Samsung Biologics Co. Ltd., Eppendorf AG, Repligen Corporation, Takara Bio Inc., KBI Biopharma Inc., Rentschler Biopharma SE, Just Biotherapeutics Inc., PBS Biotech Inc., Stobbe Group, Applikon Biotechnology

Access The Complete Report Here:

https://www.thebusinessresearchcompany.com/report/upstream-bioprocessing-global-market-report

Which Region Is Forecasted To Lead The Upstream Bioprocessing Market In The Coming Years?

North America was the largest region in the upstream bioprocessing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the upstream bioprocessing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Customize Your Report Here:

https://www.thebusinessresearchcompany.com/customise?id=15950&type=smp

Browse Through More Reports Similar to the Global Upstream Bioprocessing Market 2025, By The Business Research Company

Single Use Bioprocessing Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/single-use-bioprocessing-global-market-report

Bioprocessing Technology Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/bioprocessing-technology-global-market-report

Streaming Analytics Global Market Report 2025

https://www.thebusinessresearchcompany.com/report/streaming-analytics-global-market-report

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model